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Abstract
Background: Reduction of accidental contamination of the near-patient environment has potential to reduce
acquisition of healthcare-associated infection(s). Although medical gloves should be removed when soiled or
touching the environment, compliance is variable. The use of antimicrobial-impregnated medical gloves could
reduce the horizontal-transfer of bacterial contamination between surfaces.
Aim: Determine the activity of antimicrobial-impregnated gloves against common hospital pathogens: Streptococcus
pyogenes, carbapenem-resistant E.coli (CREC), MRSA and ESBL-producing Klebsiella pneumoniae.
Methods: Fingerpads (~1cm2) of PHMB-treated and untreated gloves were inoculated with 10 μL (~104 colony-forming-
units [cfu]) of test-bacteria prepared in heavy-soiling (0.5%BSA), blood or distilled-water (no-soiling) and sampled after 0.
25, 1, 10 or 15 min contact-time.
Donor surfaces (~1cm2 computer-keys) contaminated with wet/dry inoculum were touched with the fingerpad of
treated/untreated gloves and subsequently pressed onto recipient (uncontaminated) computer-keys.
Results: Approximately 4.50log10cfu of all bacteria persisted after 15 min on untreated gloves regardless of soil-type. In
the absence of soiling, PHMB-treated gloves reduced surface-contamination by ~4.5log10cfu (>99.99%) within 10 min of
contact-time but only ~2.5log10 (>99.9%) and ~1.0log10 reduction respectively when heavy-soiling or blood was present.
Gloves became highly-contaminated (~4.52log10–4.91log10cfu) when handling recently-contaminated computer-keys.
Untreated gloves contaminated “recipient” surfaces (~4.5log10cfu) while PHMB-treated gloves transferred fewer bacteria
(2.4–3.6log10cfu). When surface contamination was dry, PHMB gloves transferred fewer bacteria (0.3–0.6log10cfu) to
“recipient” surfaces than untreated gloves (1.0–1.9log10; P < 0.05).
Conclusions: Antimicrobial-impregnated gloves may be useful in preventing dissemination of organisms in the near-
patient environment during routine care. However they are not a substitute for appropriate hand-hygiene procedures.
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Introduction
In European hospitals, 5.7% of patients have a healthcare as-
sociated infection at any one time [1]. These infections form
a quarter of all patient-adverse events and cost 7 billion
Euros per year [2]. The emergence of multidrug resistant
Gram negative pathogens has made efforts for the reduction
of healthcare-associated infection a priority. Staff hand hy-
giene is thought to be the most effective method to prevent
transmission of these pathogens. In critical care the most
frequently touched surfaces are the bedside computer and
equipment trolley [3]. Hand hygiene compliance between
computer keyboards and surfaces within the vicinity and the
patient is poor. Adoption of electronic patient records with
hand held tablet computers on patient wards increases risk
of transmission especially as bacteria and spores may survive
there for several weeks. Although hospital infection preven-
tion policies require removal of gloves and hand hygiene be-
tween patient contact and touching nearby surfaces, this
may not be performed, particularly in the emergency situ-
ation. Soiling of gloves may not be visible to the wearer yet
harbour pathogenic organisms. Soiled/contaminated gloves
should be removed between activities but this may not be
immediate. Once organisms are transferred to any nearby
surface there is a potential for further dissemination [4, 5].
An antimicrobial additive to the glove material could
reduce the risks associated with accidental contact with
surfaces. The antimicrobial-efficacy of poly-[hexa-methy-
lene]-biguanide-hydrochloride (PHMB)-treated non ster-
ile medical gloves was tested against a range of bacteria
associated with healthcare infections. The effect on
transfer of organisms to and from computer-keyboard
surfaces under various levels of soiling is assessed.
Methods
Preparation and validity-testing of the glove material
Preparation of test organisms
Clinical isolates of carbapenem-resistant E.coli (CREC),
meticillin-resistant Staphylococcus aureus (MRSA;
EMRSA-15 variant B1), an extended-spectrum beta-
lactamase (ESBL)-producing Klebsiella pneumoniae and
a type-culture of Streptococcus pyogenes ATCC 19615
were tested.
Overnight culture of the test bacteria (10 μL) was trans-
ferred to sterile nutrient broth (10 mL; Oxoid, UK), mixed
thoroughly and incubated aerobically at 37 °C for 18 h.
Broth cultures were centrifuged at 3000 rpm (1500 × g;
Jouan CR3i centrifuge: Thermo, UK) for 10 min and the
remaining pellet re-suspended in 10 mL of 0.5% w/v Bovine
Serum Albumin (BSA) (Sigma-Aldrich, UK), sterile horse
blood (Oxoid, UK), or no soil (sterile distilled water).
Preparation of neutralising solution
Where appropriate, antimicrobial activity was inactivated
with a neutralising solution comprising: 3% (w/v) Tween
80, 0.3% (w/v) Lecithin, 1.0% (w/v) Sodium thiosulfate,
1.5% (w/v) K2HPO4, KH2PO4 0.05% (w/v), 1% (w/v)
Poly-[sodium-4-styrenesulfonate], 0.1% (v/v) Triton®
×100 (Sigma-Aldrich, UK) and prepared in Phosphate-
buffered saline (PBS) solution (Oxoid, UK). Solutions
were sterilised by autoclaving (121 °C for 15 min) and
refrigerated (2–5 °C) until required.
Validation of neutraliser efficacy and toxicity
The capacity of the neutraliser to quench the antimicro-
bial activity of PHMB was confirmed and any toxicity
against the test organisms assessed as previously de-
scribed [6]. An excised square (1 cm x1cm) from an un-
used PHMB-treated nitrile glove was immersed in 1 mL
sterile de-ionised water and incubated at room
temperature for 1 h to allow PHMB to leach into the so-
lution (PHMB leachate). A sterile test tube was dosed
with: (A) 1 mL Neutraliser +1 mL PHMB leachate + ex-
cised test-glove, (B) 1 mL Neutraliser A + 1 mL Sterile
distilled water or (C) 2 mL distilled water (control) and
incubated at room temperature for 1 min to allow neu-
tralisation of the PHMB-leachate solution. This was in-
oculated with 1 mL (103 colony-forming units [cfu]) of
S. pyogenes, CREC, MRSA or K. pneumoniae suspension
prepared in sterile distilled water.
The resulting suspensions were incubated a further
10 min at room temperature before spread-plating 0.1 mL
onto either Staph/Strep agar (S. pyogenes only) or
Columbia blood agar plates (CREC, MRSA or K. pneumo-
niae). Plates were incubated aerobically at 37 °C for 48 h.
Neutraliser efficacy (NE) and neutraliser toxicity (NT)
were calculated as:
NE ¼ MA=MB; and
NT ¼ MB=MC;where
MA, MB and MC represent the mean number of spores
recovered from preparations (A), (B) and control popu-
lations (C) respectively. Results were based on 10 repli-
cate test samples.
Using documented criteria6, the neutraliser efficacy
and toxicity ratios were calculated as being ≥0.75 for all
test-preparations (results not shown) demonstrating that
the neutraliser was effective against PHMB solution and
non-toxic to the test organisms.
Testing of the glove material
Effect of contact time on bacterial inoculum
The finger pad of the index finger of PHMB-treated and
untreated (control) gloves was marked with a 1 cm × 1 cm
test-area and the area rinsed 3 times with sterile distilled
water followed by immersion in 70% ethanol solution be-
fore allowing to air-dry. Marked-areas were inoculated with
10uL (~104cfu) of the test organism (S. pyogenes, CREC,
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MRSA or K. pneumoniae) suspended in a soil solution
(0.5% BSA or sterile horse blood) or in sterile distilled water
(DW; control) and incubated at room temperature.
After the appropriate contact time (0.25, 1, 10 or
15 min) at room temperature, test-areas on the finger
pad of gloves were excised, transferred to 2 mL neutra-
lising solution and homogenised at high speed for 30 s
by vortexing. Assays were incubated in neutraliser for
10 min at room temperature. Serial dilutions of suspen-
sions were performed prior to spread-plating 0.1 mL ali-
quots either Staph/Strep selective agar (S. pyogenes only;
Oxoid, UK) or Columbia blood agar plates (CREC,
MRSA or K. pneumoniae). Plates were incubated aerob-
ically at 37 °C for 48 h prior to reading.
Transfer from gloves to recipient-surface
A standard computer keyboard key was prepared as an
example recipient-surface. Keys were scrubbed manually
using non-chlorinated detergent then rinsed three times
using sterile distilled water followed by immersing in
70% ethanol solution and air-dried prior to use.
As previously described (section 2.1), test-areas on
treated and untreated (control) gloves were inoculated
with 10 μL (~104 cfu) of the test organism prepared in a
soil or distilled water (no soil). The inoculated gloves
were donned by the investigator either immediately (wet
inoculum) or after allowing the inoculum to dry (15 min
incubation at room temperature) and the seeded finger-
pad pressed onto an un-inoculated recipient surface
(computer key) for one second.
The recipient-surface was swabbed immediately with a
sterile cotton-tipped swab (pre-moistened in neutralising
solution) and the swab transferred to a universal tube
containing 2 mL neutralising solution. Swab suspensions
were homogenised by vortexing at high speed for 30 s
and incubated a further 10 min at room temperature.
Aliquots (0.5 mL) of the neat suspension and 0.1 mL
from 1/10 and 1/100 serial dilutions were surface-plated
onto the appropriate agar and incubated aerobically at
37 °C for 48 h prior to reading.
Transfer from donor-surfaces (computer-key) to gloves and
computer key
A test-area was marked on a standard computer key-
board key (donor-surface) and a second key (recipient-
surface) with a 1 cm × 1 cm square and decontaminated
as described previously. Donor-surfaces were seeded
with 10 μL (~104 cfu) test organism ±soil-challenge/con-
trol soil. An unused treated or untreated glove (control)
was donned by the investigator and the finger-pad of the
index-finger pressed onto a wet or dry inoculum on the
seeded donor-surface for one second. Immediately, the
same contaminated finger-pad was pressed onto a sec-
ond uncontaminated key (recipient-surface).
Donor and recipient-surfaces were swabbed immedi-
ately with a sterile cotton-tipped swab (pre-moistened in
neutralising solution) and the swab transferred to a uni-
versal tube containing 2 mL neutralising solution. Simi-
larly, the finger-pad of each contaminated glove was
excised and transferred to a universal tube containing
2 ml neutralising solution. Solutions were vortexed at
high speed for 30 s and the resulting suspension incu-
bated in the neutralising solution for 10 min at room
temperature. Aliquots (0.5 ml and 0.1 ml) of neat and
serial dilutions were plated for incubation as above.
Results
Effect of contact time on bacterial inoculum
Test gloves were inoculated with 2.8 × 104- 6.1 × 104 (i.e.
4.45 log10–4.78 log10) cfu bacteria. Approximately 4.50 log10
cfu bacteria could be recovered from both PHMB-treated
and untreated gloves when sampled immediately (Table 1).
Untreated gloves remained contaminated with high
numbers (4.50 log10 cfu) for up to 15 min with the test or-
ganisms regardless of the soil type (distilled water, 0.5%
BSA, Blood). The only exception was S. pyogenes, where
the absence of a soil (distilled water only) caused numbers
to decline by 2.5 log10 cfu over the same period.
PHMB-treated gloves effectively reduced the numbers
of S. pyogenes, CREC and MRSA by 4.50 log10 to below
the detection limit (2 cfu) and K. pneumoniae by 2.50
log10 within 10 min of contact time when a soil-
challenge was absent (distilled water only).
When the organic challenge was increased to moder-
ate soiling (0.5% BSA) PHMB-treated gloves achieved
2.5 log10 reductions (<99.9%) in S. pyogenes, CREC,
MRSA and K. pneumoniae contamination after 15 min
exposure. When a heavy soil was present (blood), reduc-
tions were only <1 log10.
Transfer from glove-tip to surface
Finger-pads of PHMB-treated and untreated (control)
gloves were inoculated with approximately 2.5 × 104-
4.8 × 104 (i.e. 4.41 log10–4.68 log10) cfu bacteria prior to
touching the recipient surface. Regardless of the soil type,
similar numbers of bacteria could be transferred from an
untreated or PHMB-treated glove to an uncontaminated
keyboard key when the inoculum was wet (Table 2).
When the contaminating inoculum was dry,
untreated-gloves were able to transfer the same numbers
of bacteria to a keyboard surface as when the contamin-
ation was wet (under all soil conditions; Table 2). How-
ever, no contamination was detected (detection limit:
2 cfu) on keyboard keys that were touched with a dried
inoculum on PHMB-treated gloves (distilled water and
0.5% BSA soil). When dry contaminated PHMB-treated
gloves were soiled with blood, between 1.5–2.5 log10
bacteria could be transferred to the recipient surface.
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Transfer from contaminated surfaces to gloves or other
surface
Keyboard keys were contaminated with approximately
3.3 × 104- 8.2 × 104 (i.e. 4.52 log10–4.91 log10) cfu bacteria
(S. pyogenes, CREC, MRSA and K. pneumoniae)
suspended in 0.5% BSA, blood or no soil (distilled water).
When recently contaminated (i.e. wet) keyboard keys
were touched with the fingertip of PHMB-treated and
untreated gloves, approximately 3–4 log10 bacteria were
transferred to these finger tips (Table 3). Where the
inoculum on the keyboard surface was dry (15 min incu-
bation at room temperature) fewer numbers of bacteria
could be transferred to the fingerpad (2.5–3.3 log10 bac-
teria) of both test and control gloves.
Transfer of bacteria from donor to recipient surfaces via
gloves
Touching a wet donor (i.e. previously contaminated)
keyboard key with the fingertip of either PHMB-treated
or untreated gloves and then immediately touching an
uncontaminated recipient keyboard key transferred
approximately 2.4–3.6 log10 cfu bacteria (Table 3).
In the presence or absence of a moderate soiling
(i.e. 0.5% BSA or DW respectively) on the donor sur-
face, between 1.0–1.9 log10 cfu bacteria (S. pyogenes,
CREC and K. pneumoniae) could be transferred with
an untreated glove to the recipient surface when the
contamination was dry (i.e. present on surface for
15 min).
Table 3 Transfer from a donor surface (keyboard key) contaminated recently with bacteria (wet inoculum) or from old
contamination (dry inoculum) to the fingertip of a gloved hand and when in the presence of different soiling conditions; n = 10
Median Log10 CFUs transferred (Inter-Quartile Range)
Organism Un-treated (control) glove PHMB-treated glove
Wet Inoculum No soiling
(DW)
Moderate soiling
(0.5% BSA)
Heavy soiling
(Blood)
No soiling
(DW)
Moderate soiling
(0.5% BSA)
Heavy soiling
(Blood)
MRSA 3.15 (3.04–3.28) 3.04 (3.00–3.46) 3.20 (3.08–3.34) 3.18 (3.04–3.28) 3.11 (3.09–3.20) 3.23 (3.20–3.32)
Carbapenem-resistant E.coli 3.34 (3.23–3.46) 3.18 (3.15–3.34) 3.30 (3.20–3.32) 3.00(2.95–3.08) 3.20 (2.70–3.23) 3.34 (3.30–3.49)
K. pneumoniae 4.03 (4.00–4.17) 4.12 (3.95–4.16)) 4.01 (3.91–4.19) 3.34 (3.34–3.38) 3.41 (3.40–3.45) 3.89 (3.78–3.96)
S. pyogenes 3.93 (3.83–3.98) 3.93 (3.89–3.97) 3.96 (3.90–4.02) 3.94 (3.90–3.95) 3.95 (3.87–4.00) 3.99 (3.97–4.07)
Dry Inoculum No soiling
(DW)
Moderate soiling
(0.5% BSA)
Heavy soiling
(Blood)
No soiling
(DW)
Moderate soiling
(0.5% BSA)
Heavy soiling
(Blood)
MRSA 2.78 (2.65–2.90) 2.78 (2.70–2.88) 3.13 (2.95–3.23) 2.73 (2.71–2.92) 2.80 (2.71–2.80) 3.35 (3.31–3.47)
Carbapenem-resistant E.coli 2.65 (2.65–2.74) 2.88 (2.70–2.88) 2.81 (2.78–2.88) 2.52 (2.52–2.65) 2.62 (2.43–2.68) 3.00 (2.92–3.28)
K. pneumoniae 3.13 (3.19–3.34) 3.28 (3.13–3.39) 3.53 (3.48–3.57) 2.65 (2.65–2.70) 2.65 (2.60–2.65) 2.48 (2.48–2.70)
S. pyogenes 3.27 (3.19–3.34) 3.30 (3.24–3.54) 3.44 (3.40–3.49) 3.13 (3.02–3.16) 3.34 (3.29–3.39) 3.36 (3.26–3.41)
Note: Numbers below the detection limit (2 CFU) are expressed as <0.301 Log10 numbers
Table 2 Transfer of bacteria from recently contaminated fingertips (wet inoculum) and old contamination (dry inoculum) to a donor
surface (keyboard key) and when in the presence of different soiling conditions; n = 10
Median Log10 CFUs transferred (Inter-Quartile Range)
Organism Un-treated (control) glove PHMB-treated glove
Wet Inoculum No soiling
(DW)
Moderate soiling
(0.5% BSA)
Heavy soiling
(Blood)
No soiling
(DW)
Moderate soiling
(0.5% BSA)
Heavy soiling
(Blood)
MRSA 4.20 (4.15–4.21) 4.08 (4.06–4.11) 4.16 (4.06–4.20) 4.06 (3.96–4.07) 4.07 (4.05–4.08) 3.99 (3.95–4.09)
Carbapenem-resistant E.coli 4.12 (4.09–4.15) 4.17 (4.12–4.11) 4.13 (4.12–4.23) 4.08 (4.08–4.13) 4.10 (4.08–4.13) 4.19 (4.16–4.26)
K. pneumoniae 4.39 (4.36–4.40) 4.29 (4.25–4.45) 4.20 (4.19–4.34) 4.39 (4.25–4.40) 4.28 (4.27–4.31) 4.35 (4.29–4.39)
S. pyogenes 4.54 (4.47–4.59) 4.65 (4.60–4.66) 4.75 (4.73–4.780 4.59 (4.25–4.40) 4.54 (4.41–4.57) 4.52 (4.45–4.56)
Dry Inoculum No soiling
(DW)
Moderate soiling
(0.5% BSA)
Heavy soiling
(Blood)
No soiling
(DW)
Moderate soiling
(0.5% BSA)
Heavy soiling
(Blood)
MRSA 4.09 (4.07–4.20) 4.21 (4.20–4.23) 4.21 (4.17–4.23) <0.301 <0.301 1.68 (1.64–1.72)
Carbapenem-resistant E.coli 3.74 (3.69–3.80) 4.12 (4.10–4.16) 4.19 (4.15–4.27) <0.301 <0.301 2.12 (2.05–2.40)
K. pneumoniae 4.36 (4.33–4.39) 4.34 (4.29–4.40) 4.43 (4.39–4.48) <0.301 <0.301 1.38 (1.38–1.60)
S. pyogenes 4.29 (4.26–4.34) 4.59 (4.57–4.61) 4.66 (4.58–4.69) <0.301 <0.301 2.77 (2.70–2.82)
Note: Numbers below the detection limit (2 CFU) are expressed as <0.301 Log10 numbers
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Under the same conditions, between 0.3–0.6 log10 cfu
bacteria were transferred to recipient surfaces using the
PHMB-treated gloves. The numbers of MRSA transferred
from donor to recipient surfaces were the same whether
treated or untreated gloves were donned. No difference
was observed in the numbers of bacteria transferred from
donor to recipient surfaces using either treated or un-
treated gloves when blood soiling was present (P > 0.05).
Discussion
The most frequent causes of healthcare-associated infec-
tions are E. coli (15.9%), S. aureus (12.3%) and Klebsiella
spp. (8.7%) [1]. All of these may be spread on hands.
Hand hygiene compliance varies widely depending on
the staff category, clinical setting, and whether gloves
are worn during patient care [7, 8].
Gloves are an essential part of personal protective
equipment but not a substitute for hand hygiene. The use
of medical examination gloves during patient-care is rec-
ommended as a “barrier” to infectious organisms in cases
where contact with bodily fluids, mucous membranes or
damaged skin is likely. However gloves should always be
removed and hands decontaminated when moving away
from the immediate patient-environment [9, 10]. The in-
appropriate use of gloves has been implicated in the cross
transmission of clinically significant pathogens in the ICU
setting [11]. In one study, it was shown only 5% of health-
care workers wearing gloves were likely to contaminate
the skin of their hands after routine patient care compared
to not wearing gloves (37%), demonstrating the benefits of
a “barrier-protection” [12].
The various activities associated with patient care in-
crease the likelihood of transmission of organisms from
an infected patient to surfaces in their vicinity, especially
in situations where there is repeated contact between
staff, patient and environment. For example, during in-
duction of anaesthesia the number of gloved-hand con-
tact between the patient and environment is too
frequent to allow hand-hygiene on every occasion.
In an effort to prevent the transmission of micro-
organisms during procedures involving patient contact,
double-gloving of the hands was implemented in an an-
aesthetic operating room. Removal of the outer glove of
a double-layer significantly reduced the presence of con-
taminating organisms in the intraoperative environment,
suggesting the rapid elimination of microorganisms on
the surfaces of the hands may reduce the risk of cross-
transmission from surfaces near patients. However, the
implementation of double-layer gloving to complement
hand hygiene may not be practical in emergency care sit-
uations. Consequently, the use of gloves impregnated
with antimicrobial agents would be expected to reduce
the risk of transmission from a patient to their environ-
ment and then to another patient [8].
PHMB is a broad spectrum antimicrobial agent sup-
ported under Directive 98/8/EC for use as a disinfectant.
It is used as a preservative and as an antimicrobial agent
in wet wipes, to prevent microbial contamination in
wound irrigant or gel and sterile dressings, and to disin-
fect hard surfaces for food handling in institutions and
hospitals. In a randomised controlled trial of impreg-
nated dressings, it was superior to silver in reduction of
bacterial load in chronic wounds [13]. However the EU
Scientific Committee did not recommend its use in cos-
metics as 0.3% preservative or spray-formulation [14].
In this study we showed PHMB-treated nitrile gloves can
reduce S. pyogenes, CREC and MRSA contamination by
~4.5 log10 cfu (~99.99% reduction) to below the detection
limit (2 cfu) within 10 min of contact time. There is an ap-
proximate 2.5 log10 cfu reduction of K. pneumoniae. This
demonstrates a potential for PHMB-treated gloves to re-
duce the risk of contaminating nearby surfaces. Both
PHMB-treated and untreated glove types could transfer
high numbers of contaminating bacteria to uncontaminated
surfaces if still wet. However, PHMB-treated gloves that
were donned for 15 min (i.e. when the contaminating in-
oculum was visibly dry) did not transfer bacteria to uncon-
taminated surfaces in the absence of soil or when only
moderate soiling (0.5% BSA) was present.
The concentration of contaminating organisms carried
in an inoculum may influence the degree of cross-
contamination. Hands or gloves contaminated with a small
inoculum concentration may result in greater percentage
transfer to an un-contaminated surface than a large inocu-
lum [15]. Therefore, reductions in bacterial numbers to
low numbers on a glove using antimicrobial PHMB may
not directly correlate to a relative risk-reduction in poten-
tial cross-contamination of these organisms. Nonetheless,
the efficacies demonstrated in our study show numbers
may be reduced to below the detection limit (2 cfu) in
short contact times (i.e. 10 min). The risk of spread could
be further minimised if gloves are removed and changed
between frequently and between activities.
A criticism of the study is that glove fingertip pads were
homogenized to remove bacteria instead of using a swab-
bing technique. Homogenisation of the excised fingerpad
of the glove allows the capture of bacterial cells from the
microscopic contours of the glove material that may other-
wise be inaccessible if using a swab. The antimicrobial
PHMB additive was impregnated uniformly throughout
the treated-glove material during manufacture and not ap-
plied superficially, thus minimising variation between
structure and microscopic surface with the untreated (con-
trol) glove. More bacteria may be deposited from a glove
than from a bare hand [16]. While swabbing will indicate
the potential transfer of superficial contaminating cells
homogenisation will permit the isolation of cells trans-
ferred in successive contacts to uncontaminated surfaces.
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The application of antimicrobial PHMB in medical
examination gloves has been evaluated recently [17]. How-
ever, in that assessment, the contaminating numbers were
low (up to 102 cfu) and did not address the potential risks
of cross-transfer to uncontaminated surfaces. In another
study the antimicrobial efficacy of PHMB impregnated
gloves was enhanced with the application of pressure (75 g
weight for 1 min) to increase contact with the inoculum
and therefore facilitating antimicrobial activity [18].
The antimicrobial potential of gloves impregnated with
a variety of antimicrobial agents other than PHMB have
been explored, though the design and test-criteria for
the selection and development of antimicrobial gloves
vary depending on the end-use and requirement pre-
determined by the investigator.
Gentian violet and chlorhexidine impregnated into PVA
gloves demonstrated rapid bactericidal activity against sev-
eral clinically relevant pathogens (MRSA, vancomycin-
resistant enterocci, multidrug-resistant Pseudomonas aeru-
ginosa, and a carbapenemase producing Klebsiella pneumo-
niae) when assessed following the criteria described within
the JIS Z 2801 standard for the determination of anti-
microbial non-porous surfaces [19]. However, this test re-
quires the application of glass cover-slips to increase
surface contact and does not incorporate an interfering-
substance/soil challenge, therefore permitting “enhanced”
in-vitro antimicrobial activity that may not be achievable
under realistic conditions. In the current study, antimicro-
bial activity was assessed without the application of en-
hanced pressure or cover slips to maximise contact. The
presence of heavy soils, such as blood, limited bacterial re-
duction on PHMB-treated gloves to <1 log10 cfu. None-
theless, the transfer of bacteria from PHMB-treated glove
was significantly less compared with untreated gloves re-
gardless of whether the contamination was recent or up to
15 min old (P < 0.05).
During use, micro-perforation of the medical examin-
ation glove is common [20, 21]. Loss of structural integrity
may result in the bi-directional migration of contaminating
organisms between the hands of the HCW, the patient and
proximal surfaces in the clinical environment. In one study,
chlorhexidine gluconate in a matrix on the inside of gloves
was used to protect the staff member from accidental punc-
ture contamination with body fluids [22]. In another study,
coating antimicrobial chlorhexidine digluconate onto the
inner surfaces of a glove demonstrated antimicrobial effi-
cacy against S. aureus and K. pneumoniae for up to two-
hours of continued use in a surgical setting [23].
A study by Reitzel, et al. showed rapid bactericidal ac-
tivity for gloves impregnated with brilliant green and
chlorhexidine but the organic solvents required in the
process compromised glove integrity [19]. Compatibility
of the glove material with the antimicrobial agent and
the intended use should therefore be addressed prior, as
disintegration of the glove material may expose the
wearer to potentially pathogenic organisms. In the
current study, the inner surfaces of the treated gloves
used in the current study were not assessed for anti-
microbial activity. However, the PHMB agent used was
distributed throughout the inner and outer surfaces of
the glove. This property indicates PHMB-impregnated
gloves may reduce the risk of bacterial transfer upon
puncture of the glove material. Although not assessed,
the nitrile examination gloves evaluated in our study
were designed to be compatible with the PHMB anti-
microbial additive and did not compromise the physical
integrity of the material during testing.
In conclusion, the use of antimicrobial nitrile gloves
has a potential benefit in the clinical environment in re-
ducing accidental environmental contamination. Soiling
(e.g. blood) significantly reduces the efficacy of such ma-
terials so the gloves will have less effect on transfer of
organisms between different sites on the patient. The
test criteria for the evaluations of antimicrobial activity
should be based upon realistic measures and relevance
to the application and setting.
The use of medical examination gloves treated with
antimicrobial agents (e.g. PHMB) should be utilised in
conjunction with appropriate hand hygiene practices
and gloves changed frequently between activities and
after prolonged use.
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